Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 2 | |
Hold | 4 | |
Sell | 2 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Pacira Biosciences Inc have a median target of 18.50, with a high estimate of 56.00 and a low estimate of 8.00. The median estimate represents a 25.94% increase from the last price of 14.69.
High | 281.2% | 56.00 |
Med | 25.9% | 18.50 |
Low | -45.5% | 8.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate | +7.28% |
Average growth rate | +15.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | +1.51% |
Average growth rate | +13.11% |
More ▼